Hepatitis Awareness Month

Hepatitis Awareness Month

May is designated as Hepatitis Awareness Month in the United States, providing 31 days to raise awareness of viral hepatitis in the United States. During May, agencies and offices across the federal government as well as state and local partners work to raise awareness of the importance of vaccination for hepatitis A and B, testing for hepatitis B and C, the availability of effective care and curative treatment, and the serious health consequences resulting from undiagnosed and untreated viral hepatitis.

Use the Hepatitis Digital Tools

Incorporate the Hepatitis Awareness Month logo into your website, blog posts, social media, email, and other communications. Visit the Centers for Disease Control and Prevention (CDC) page to find an array of digital tools including a quiz widget and buttons, badges, and banners in different shapes and sizes that are ready to download and use online.

Hepatitis Testing Day

The month-long observance includes Hepatitis Testing Day on May 19th. These observances are important opportunities to raise widespread awareness of viral hepatitis and its impact in the U.S. and expand our coordinated national efforts to improve the health of the estimated 862,000 people living with hepatitis B and 2.4 million people living with hepatitis C.

Millions of Americans have chronic viral hepatitis; most of them do not know they have it. The goal of Hepatitis Testing Day is to help raise awareness of hepatitis B and hepatitis C and to encourage more individuals to learn their status. It is a day for people at risk for viral hepatitis to be tested, and for health care providers to educate patients about viral hepatitis and testing.

Hepatitis Testing Day is an important opportunity for stakeholders across all sectors of society to educate their constituents and communities about viral hepatitis and encourage those at risk to be tested. First observed in 2012, Hepatitis Testing Day was designated as a national observance in 2013, to help raise awareness of the silent epidemic of viral hepatitis in the United States.

An estimated 862,000 people are living with hepatitis B and 2.4 million are people living with hepatitis C. Most people with chronic hepatitis B virus or hepatitis C virus don’t have symptoms until the later stages of the infection. As a result, many Americans living with viral hepatitis do not know they are infected and are at risk for severe, even fatal, complications from the disease and can spread the virus to others. Untreated chronic viral hepatitis represents a leading cause of liver cancer and the most common reason for liver transplantation in the United States. Treatment for hepatitis B is available and can prevent the development of liver disease and liver cancer. Hepatitis C kills more Americans than any other reportable infectious disease yet safe and effective oral treatments are available that cure hepatitis C in one 8 to 12 week course in greater than 95% of infected people, preventing liver disease and liver cancer. Testing individuals at risk for hepatitis B and hepatitis C and linking those chronically infected to medical care and treatment can reduce related illness and death.

Be sure to visit our Hepatitis Awareness Month page for additional events and campaigns across the country.

Member rating:
Contact CTA
Members CTA
Events Calendar

Sign up to our mailing list

Receive the latest resources, training and news direct to your inbox!

Please complete the form below.